Technical Analysis for ANVS - Annovis Bio, Inc.
Grade | Last Price | % Change | Price Change |
---|---|---|---|
C | 26.54 | 0.11% | 0.03 |
ANVS closed up 0.11 percent on Friday, April 9, 2021, on 36 percent of normal volume. It was able to find support at its 50 day moving average. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.
ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Weak or Absent | Up | Up | Down |
Historical ANVS trend table... |
Date | Alert Name | Type | % Chg |
---|---|---|---|
50 DMA Support | Bullish | 0.00% | |
Lizard Bullish | Bullish Day Trade Setup | 0.00% | |
Non-ADX 1,2,3,4 Bullish | Bullish Swing Setup | 0.00% | |
Narrow Range Bar | Range Contraction | 0.00% | |
Doji - Bullish? | Reversal | 0.00% | |
Wide Bands | Range Expansion | 0.00% | |
Oversold Stochastic | Weakness | 0.00% | |
Non-ADX 1,2,3,4 Bullish | Bullish Swing Setup | 0.11% | |
Narrow Range Bar | Range Contraction | 0.11% | |
NR7 | Range Contraction | 0.11% |
Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App
Alert | Time |
---|---|
60 Minute Opening Range Breakdown | 1 day ago |
50 DMA Support | 1 day ago |
Down 3% | 1 day ago |
Down 2 % | 1 day ago |
Down 1% | 1 day ago |
Free Daily (Stock) Chart Reading
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: ???
Annovis Bio, Inc. develops drugs for Alzheimer's and Parkinson's diseases and other neurodegenerative disorders. It offers posiphen compound for mild cognitive impairment and early stage Alzheimer's disease and bisnorcymserine compound that inhibits amyloid formation and prevents the progression of the Alzheimer's disease. The company was founded by Maria Luisa Maccecchini in May 2008 and is headquartered in Berwyn, PA.
Sector: Healthcare
Industry: Biotechnology
Keywords: Organ Systems Alzheimer's Disease Mild Novi Psychiatric Diagnosis Amyloid Nervous System Neurodegeneration Alzheimer's Neurodegenerative Disorders Cognitive Disorders Cognitive Impairment Learning Disabilities Neuroprotection Gladstone Institutes Parkinson's Diseases
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Organ Systems Alzheimer's Disease Mild Novi Psychiatric Diagnosis Amyloid Nervous System Neurodegeneration Alzheimer's Neurodegenerative Disorders Cognitive Disorders Cognitive Impairment Learning Disabilities Neuroprotection Gladstone Institutes Parkinson's Diseases
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 47.93 |
52 Week Low | 3.08 |
Average Volume | 363,154 |
200-Day Moving Average | 10.92 |
50-Day Moving Average | 26.17 |
20-Day Moving Average | 30.97 |
10-Day Moving Average | 27.82 |
Average True Range | 3.49 |
ADX | 23.49 |
+DI | 19.46 |
-DI | 23.98 |
Chandelier Exit (Long, 3 ATRs ) | 37.47 |
Chandelier Exit (Short, 3 ATRs ) | 35.71 |
Upper Bollinger Band | 38.75 |
Lower Bollinger Band | 23.18 |
Percent B (%b) | 0.22 |
BandWidth | 50.27 |
MACD Line | 0.01 |
MACD Signal Line | 0.99 |
MACD Histogram | -0.9894 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 28.97 | ||||
Resistance 3 (R3) | 28.81 | 27.84 | 28.56 | ||
Resistance 2 (R2) | 27.84 | 27.22 | 27.92 | 28.43 | |
Resistance 1 (R1) | 27.19 | 26.84 | 26.71 | 27.35 | 28.29 |
Pivot Point | 26.22 | 26.22 | 25.98 | 26.30 | 26.22 |
Support 1 (S1) | 25.57 | 25.60 | 25.09 | 25.73 | 24.79 |
Support 2 (S2) | 24.60 | 25.22 | 24.68 | 24.65 | |
Support 3 (S3) | 23.95 | 24.60 | 24.52 | ||
Support 4 (S4) | 24.11 |